Comparative evaluation of standard and dual-treated insecticide bednets in Sud Ubangi, Democratic Republic of Congo
Not Applicable
Active, not recruiting
- Conditions
- MalariaInfections and InfestationsUnspecified malaria
- Registration Number
- ISRCTN99611164
- Lead Sponsor
- iverpool School of Tropical Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- Female
- Target Recruitment
- 86000
Inclusion Criteria
Women attending first ANC appointment at a clinic that is taking part in the study and who consent to be enrolled in the study
Exclusion Criteria
1. Young adolescents (<15 years)
2. Women presenting with symptoms of severe malaria
3. Women suffering from other illness requiring prompt treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular targets do dual-treated insecticide bednets address to combat pyrethroid-resistant malaria vectors in Sud Ubangi?
How does dual insecticide bednet efficacy compare to standard pyrethroid-treated nets in reducing Plasmodium falciparum prevalence in DRC?
Which mosquito resistance biomarkers predict differential effectiveness of standard versus dual-treated bednets in Sud Ubangi's malaria-endemic regions?
What adverse events were reported in large-scale bednet distribution programs in DRC, and how were they managed?
How do synergistic insecticide combinations in dual-treated bednets enhance malaria vector control compared to monotherapy approaches in sub-Saharan Africa?